Literature DB >> 30920428

Peripheral oxytocin restores light touch and nociceptor sensory afferents towards normal after nerve injury.

M Danilo Boada1, Silvia Gutierrez, James C Eisenach.   

Abstract

Oxytocin reduces primary sensory afferent excitability and produces analgesia in part through a peripheral mechanism, yet its actions on physiologically characterized, mechanically sensitive afferents in normal and neuropathic conditions are unknown. We recorded intracellularly from L4 dorsal root ganglion neurons characterized as low-threshold mechanoreceptors (LTMRs) or high-threshold mechanoreceptors (HTMRs) in female rats 1 week after L5 partial spinal nerve injury or sham control (n = 24 rats/group) before, during, and after ganglionic perfusion with oxytocin, 1 nM. Nerve injury desensitized and hyperpolarized LTMRs (membrane potential [Em] was -63 ± 1.8 mV in sham vs -76 ± 1.4 mV in nerve injury; P < 0.001), and sensitized HTMRs without affecting Em. In nerve-injured rats, oxytocin depolarized LTMRs towards normal (Em = -69 ± 1.9 mV) and, in 6 of 21 neurons, resulted in spontaneous action potentials. By contrast, oxytocin hyperpolarized HTMRs (Em = -68 ± 2.7 mV before vs -80 ± 3.2 mV during oxytocin exposure; P < 0.01). These effects were reversed after removal of oxytocin, and oxytocin had minimal effects in neurons from sham surgery animals. Sensory afferent neurons immunopositive for the vasopressin 1a receptor were larger (34 ± 6.3 μm, range 16-57 μm) than immunonegative neurons (26 ± 3.4 μm, range 15-43 μm; P < 0.005). These data replicate findings that neuropathic injury desensitizes LTMRs while sensitizing HTMRs and show rapid and divergent oxytocin effects on these afferent subtypes towards normal, potentially rebalancing input to the central nervous system. Vasopressin 1a receptors are present on medium to large diameter afferent neurons and could represent oxytocin's target.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30920428      PMCID: PMC9523380          DOI: 10.1097/j.pain.0000000000001495

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  56 in total

Review 1.  A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.

Authors:  Elayne MacDonald; Mark R Dadds; John L Brennan; Katrina Williams; Florence Levy; Avril J Cauchi
Journal:  Psychoneuroendocrinology       Date:  2011-03-23       Impact factor: 4.905

2.  Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia.

Authors:  Asako Kubo; Masamichi Shinoda; Ayano Katagiri; Mamoru Takeda; Tatsuro Suzuki; Junichi Asaka; David C Yeomans; Koichi Iwata
Journal:  Pain       Date:  2017-04       Impact factor: 6.961

3.  Oxytocin nasal spray in fibromyalgic patients.

Authors:  S Mameli; G M Pisanu; S Sardo; A Marchi; A Pili; M Carboni; L Minerba; G Trincas; M G Carta; M R Melis; R Agabio
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

4.  Oxytocin-induced membrane hyperpolarization in pain-sensitive dorsal root ganglia neurons mediated by Ca(2+)/nNOS/NO/KATP pathway.

Authors:  L Gong; F Gao; J Li; J Li; X Yu; X Ma; W Zheng; S Cui; K Liu; M Zhang; W Kunze; C Y Liu
Journal:  Neuroscience       Date:  2015-01-21       Impact factor: 3.590

5.  Oxytocin Modulates Nociception as an Agonist of Pain-Sensing TRPV1.

Authors:  Yelena Nersesyan; Lusine Demirkhanyan; Deny Cabezas-Bratesco; Victoria Oakes; Ricardo Kusuda; Tyler Dawson; Xiaohui Sun; Chike Cao; Alejandro Martin Cohen; Bharath Chelluboina; Krishna Kumar Veeravalli; Katharina Zimmermann; Carmen Domene; Sebastian Brauchi; Eleonora Zakharian
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

6.  Oxytocin activates calcium signaling in rat sensory neurons through a protein kinase C-dependent mechanism.

Authors:  Ahmet Ayar; Mete Ozcan; Ergul Alcin; Ihsan Serhatlioglu; Sibel Ozcan; Selim Kutlu; Haluk Kelestimur
Journal:  J Physiol Biochem       Date:  2013-08-06       Impact factor: 4.158

7.  Nerve injury induces a new profile of tactile and mechanical nociceptor input from undamaged peripheral afferents.

Authors:  M Danilo Boada; Silvia Gutierrez; Carol A Aschenbrenner; Timothy T Houle; Ken-Ichiro Hayashida; Douglas G Ririe; James C Eisenach
Journal:  J Neurophysiol       Date:  2014-10-01       Impact factor: 2.974

8.  Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons.

Authors:  Rafael Taeho Han; Han-Byul Kim; Young-Beom Kim; Kyungmin Choi; Gi Yeon Park; Pa Reum Lee; JaeHee Lee; Hye Young Kim; Chul-Kyu Park; Youngnam Kang; Seog Bae Oh; Heung Sik Na
Journal:  Korean J Physiol Pharmacol       Date:  2018-02-23       Impact factor: 2.016

9.  Resolution of pain after childbirth.

Authors:  James C Eisenach; Peter Pan; Richard M Smiley; Patricia Lavand'homme; Ruth Landau; Timothy T Houle
Journal:  Anesthesiology       Date:  2013-01       Impact factor: 8.986

10.  Oxytocin-induced antinociception in the spinal cord is mediated by a subpopulation of glutamatergic neurons in lamina I-II which amplify GABAergic inhibition.

Authors:  Jean-Didier Breton; Pierre Veinante; Sandra Uhl-Bronner; Angela Maria Vergnano; Marie José Freund-Mercier; Rémy Schlichter; Pierrick Poisbeau
Journal:  Mol Pain       Date:  2008-05-29       Impact factor: 3.395

View more
  3 in total

1.  Transcriptomes in rat sciatic nerves at different stages of experimental autoimmune neuritis determined by RNA sequencing.

Authors:  Y Xue; P Yin; G Li; D Zhong
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

2.  Advances in Head and Neck Cancer Pain.

Authors:  Y Ye; D D Jensen; C T Viet; H L Pan; W M Campana; M Amit; M D Boada
Journal:  J Dent Res       Date:  2022-04-13       Impact factor: 8.924

3.  Recurrent antinociception induced by intrathecal or peripheral oxytocin in a neuropathic pain rat model.

Authors:  Abimael González-Hernández; Antonio Espinosa De Los Monteros-Zuñiga; Guadalupe Martínez-Lorenzana; Miguel Condés-Lara
Journal:  Exp Brain Res       Date:  2019-09-12       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.